spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Furosemide 

 HSMN NewsFeed - 24 Jul 2020
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 26 Apr 2017
John Tucker appointed as Chief Executive Officer of scPharmaceuticals
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 28 Feb 2017
RenalGuard(R) Shown to Significantly Protect High-Risk Patients Undergoing Coronary Interventional Procedures from Acute Kidney Injury
Devices Interventional
 HSMN NewsFeed - 19 Jan 2016
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 17 Aug 2015
European Commission Grants Marketing Authorisation for Unituxin(TM) (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 May 2013
Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights to PERTZYE(R) (pancrelipase) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 3 May 2010
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 Oct 2009
Baxter Announces the Commercial Launch of HYLENEX at ACEP for Use in Pediatric Rehydration
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2008
Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
Biopharmaceuticals
 HSMN NewsFeed - 10 Sep 2007
Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Jun 2007
Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Apr 2007
Baxter Introduces HYLENEX for Use in Ophthalmic Surgery
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 14 Feb 2007
Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX From the Infuse-Morphine Study
Biopharmaceuticals
 HSMN NewsFeed - 14 Feb 2007
Halozyme and Baxter Expand Global HYLENEX Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 14 Nov 2006
NovaCardia Presents Phase II Data for KW-3902 at American Heart Association's 79th Annual Scientific Sessions
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Sep 2006
Ranbaxy Receives Approval to Commercialize Furosemide Tablets in the U.S.
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Jun 2006
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
Biopharmaceuticals
 HSMN NewsFeed - 8 Feb 2006
Halozyme Therapeutics and Baxter Release Results From the INFUSE-LR Study
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 16

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 16 additional stories matching:
Furosemide
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.